Conclusive meta-analyses on antenatal magnesium may be inconclusive! Are we underestimating the risk of random error?

Acta Obstetricia et Gynecologica Scandinavica

Volumn 91, Issue 11, 2012, Pages 1247-1251

  Brok, Jesper ^a   Huusom, Lene D ^b   Thorlund, Kristian ^a,c  

^a Rigshospitalet   (Denmark)

^b HVIDOVRE HOSPITAL   (Denmark)

^c MCMASTER UNIVERSITY   (Canada)

Author keywords

Cerebral palsy; magnesium sulfate; meta analysis; preterm; random error; randomized clinical trial; trial sequential analysis

Indexed keywords

MAGNESIUM SULFATE;

ANALYTIC METHOD; CEREBRAL PALSY; CLINICAL PRACTICE; EFFECT SIZE; HIGH RISK POPULATION; HUMAN; META ANALYSIS; PREMATURE LABOR; PRENATAL CARE; PRIORITY JOURNAL; RANDOM ERROR; REVIEW; TRIAL SEQUENTIAL ANALYSIS;

CEREBRAL PALSY; FEMALE; HUMANS; MAGNESIUM SULFATE; PREGNANCY; PRENATAL CARE; TOCOLYTIC AGENTS;

EID: 84868325944     PISSN: 00016349     EISSN: 16000412     Source Type: Journal    
DOI: 10.1111/aogs.12021     Document Type: Review

References (21)

1. Huusom LD, Brok J, Hegaard HK, Pryds O, Secher NJ,. Does antenatal magnesium sulphate prevent cerebral palsy in preterm infants? The final trial Acta Obstet Gynecol Scand. 2012; 91:1346-7.
2. Higgins JPT, Green S, (eds). Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 [updated March 2011]. The Cochrane Collaboration, 2011. Available from http://www.cochrane-handbook.org.
3. Guyatt GH, Oxman AD, Vist GE, Kunz R, Falck-Ytter Y, Alonso-Coello P, et al,. GRADE: an emerging consensus on rating quality of evidence and strength of recommendations. Br Med J. 2008; 336: 924-6.
4. Chan AW, Hrobjartsson A, Haahr M, Gotzsche P, Altman D,. Empirical evidence for selective reporting of outcomes in randomized trials. comparison of protocols to published articles. J Am Med Assoc. 2004; 291: 2457-65.
5. Chan AW, Altman D,. Outcome reporting bias in randomized trials funded by the Canadian Institutes of Health Research. Can Med Assoc J. 2004; 171: 735-40.
6. Dwan K, Alman D, Arnaiz J, Bloom J, Chan AW, Cronin E, et al,. Systematic review of the empirical evidence of study publication bias and outcome reporting bias. PLoS Med. 2008; 3: e3081.
7. Moher D, Pham B, Jones A, Cook DJ, Jadad AR, Moher M, et al,. Does quality of reports of randomised trials affect estimates of intervention efficacy reported in meta-analyses Lancet. 1998; 352: 609-13.
8. Guyatt G, Oxman AD, Kunz R, Brozek J, Alonso-Coello P, Rind D, et al,. GRADE Guidelines: 6. Rating the quality of evidence-imprecision. J Clin Epidemiol. 2011; 64: 1283-93.
9. Thorlund K, Devereaux PJ, Wetterslev J, Guyatt G, Ioannidis JP, Thabane L, et al,. Can trial sequential monitoring boundaries reduce spurious inferences from meta-analyses Int J Epidemiol. 2009; 38: 276-86.
10. Wetterslev J, Thorlund K, Brok J, Gluud C,. Trial sequential analysis may establish when firm evidence is reached in cumulative meta-analysis. J Clin Epidemiol. 2008; 61: 64-75.
11. Brok J, Thorlund K, Gluud C, Wetterslev J,. Trial sequential analysis reveals insufficient information size and potentially false positive results in many meta-analyses. J Clin Epidemiol. 2008; 61: 763-9.
12. Brok J, Thorlund K, Wetterslev J, Gluud C,. Apparently conclusive meta-analyses may be inconclusive-Trial sequential analysis adjustment of random error risk due to repetitive testing of accumulating data in apparently conclusive neonatal meta-analyses. Int J Epidemiol. 2009; 38: 287-98.
13. Thorlund K, Imberger G, Walsh M, Chu R, Gluud C, Wetterslev J, et al,. The number of patients and events required to limit the risk of overestimation of intervention effects in meta-analysis-a simulation study. PLoS One. 2011; 6: e25491.
14. Pogue J, Yusuf S,. Cumulating evidence from randomized trials: utilizing sequential monitoring boundaries for cumulative meta-analysis. Control Clin Trials. 1997; 18: 580-93.
15. DeMets D, Lan KK,. Interim analysis: the alpha spending function approach. Stat Med. 1994; 12: 1341-52.
16. Thorlund K, Engstrom J, Imberger G, Brok J, Wetterslev J, Gluud C,. Software and user manual for Trial Sequential Analysis. Available from http://www.ctu.dk/tsa/.
17. Doyle LW, Crowther CA, Middleton P, Marret S, Rouse D,. Magnesium sulphate for women at risk of preterm birth for neuroprotection of the fetus. Cochrane Database Syst Rev. 2009; 21 (1): CD004661.
18. Huusom LD, Secher NJ, Pryds O, Whitfield K, Gluud C, Brok J,. Antenatal magnesium sulphate may prevent cerebral palsy in preterm infants-but are we convinced? Evaluation of an apparently conclusive meta-analysis with trial sequential analysis. Br J Obstet Gynaecol. 2011; 118: 1-5.
19. Thorlund K, Anema A, Mills E,. Interpreting meta-analysis according to the adequacy of sample size. An example using isoniazid chemoprophylaxis for tuberculosis in purified protein derivative negative HIV-infected individuals. Clin Epidemiol. 2010; 2: 57-66.
20. Doyle L, Crowther C, Middleton P, Voysey M, Marret S, Rouse D,. Antenatal magnesium sulphate to prevent cerebral palsy in very preterm infants. Br J Obstet Gynaecol. 2011; 118: 891-2.
21. Wetterslev J, Imberger G,. The information gap between the required and the actual accrued information size in the meta-analysis of antenatal magnesium sulphate to prevent cerebral palsy in preterm infants. Br J Obstet Gynaecol. 2011; 118: 890.